ERF Eurofins Scientific SE

94.11USD85.62 EUR · EPA-0.05%Mkt Cap: 16.10B USDP/E: 29.74

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and huma…

Institutional holders14 on file

Key Statistics

Company
Market Cap16.10B USD
Enterprise Value20.62B USD
Revenue (TTM)8.12B USD
Gross Profit5.46B USD
Net Income (TTM)521.90M USD
Revenue/Share45.99 USD
Last Price94.11 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees65.0K
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISINFR0014000MR3
Valuation
P/E (Trailing)29.74
P/E (Forward)18.06
PEG1.03
EV/EBITDA12.20
EV/Revenue2.54
P/S1.98
P/B4.11
EPS (TTM)3.17 USD
EPS (Forward)5.21 USD
52W Range
61.9389% of range98.14
52W High98.14 USD
52W Low61.93 USD
Profitability
Gross Margin68.12%
Oper. Margin14.08%
EBITDA Margin20.81%
Profit Margin6.51%
ROE10.45%
ROA4.32%
ROIC7.20%
ROCE9.56%
Growth
Revenue Growth2.50%
Earnings Growth28.40%
Cash Flow & Leverage
Operating CF1.54B USD
CapEx (TTM)917.61M USD
FCF Margin4.60%
FCF Yield2.32%
Net Debt4.24B USD
Net Debt/EBITDA2.51
Net Debt/FCF11.35
Balance Sheet
Debt/Equity0.98
Current Ratio1.13
Quick Ratio0.87
Book Value/Sh22.92 USD
Cash/Share3.91 USD
Dividends
Fwd Div Rate0.79 USD
Trail. Div Rate0.79 USD
Div. Yield0.84%
5Y Avg Yield1.12%
Payout Ratio25.00%
Ex-Div DateApr 28, 2026
Pay Date—
Splits
Last Split10:1
Split DateNov 19, 2020
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)82.20 USD
Upside (mean)-12.7%
Target Range66.50 USD – 101.68 USD
66.50-12.7% to mean101.68
# Analysts14
Ownership
Shares Out.171.00M
Float108.30M
Insiders36.55%
Institutions35.66%
Technical
SMA 5088.66 (+6.2%)
SMA 20076.51 (+23.0%)
Beta0.87
S&P 52W Chg12.00%
Avg Vol (30d)267.77K
Avg Vol (10d)246.58K
Technical Indicators
RSI (14)54.1
MACD1.5718
MACD Signal2.2842
MACD Hist.-0.7124
BB Upper98.55 USD
BB Middle95.69 USD
BB Lower92.82 USD
BB Width5.99%
ATR (14)1.853 USD
Vol Ratio (20d)1.70x

About Eurofins Scientific (EPA: ERF)

›

Eurofins Scientific (EPA: ERF) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 65,000 employees.

The shares were at 85.62 EUR on 20 November 2026, up 50.0% over 52 weeks. Its 52-week range is 56.34 EUR to 89.28 EUR: the price is 4.1% below the high and 52.0% above the low.

At a market capitalisation of 14.65B EUR, it trades at 29.7 times trailing earnings and 18.1 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 17% for ERF. It pays a dividend yielding 0.84% (it pays out 25% of its earnings), against a median of 0.73% among the dividend payers in that peer group.

Eurofins Scientific reports return on equity of 10.5%, an operating margin of 14.1% and revenue up 2.5% year over year.

Its debt exceeds its cash by 3.85B EUR, a debt-to-equity ratio of 0.98. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 14 analysts cover the stock, with an average rating of Hold; their mean price target of 74.78 EUR is 12.7% below the current price. The next earnings report is expected on 28 January 2027.